The private equity firm Tata Capital Ltd.'s healthcare-focused arm, Tata Capital Healthcare Fund, has contributed $10 million (₹83.3 crore) in a combination of primary and secondary investments to the financing round for the dialysis service chain Apex Kidney Care. The new funds will be used by the healthcare chain with headquarters in Mumbai to extend its dialysis services throughout the nation. Notably, in the past month, there have been two transactions in the nephrology space. Using a combination of primary and secondary investments, Asia Healthcare Holdings (AHH) paid ₹600 crore ($72.1 million) in September to acquire a majority stake in the Asian Institute of Nephrology and Urology (AINU). "As we plan to ramp up our existing infrastructure, we will continue to partner with clinicians in both existing and newer geographies," stated Indranil Roy Choudhury, CEO of Apex Kidney Care. "Dialysis services and kidney care are the main offerings of
Apex Kidney Care, which also operates a chain of dialysis facilities. It currently runs 180 or so of these centers in 120 Indian cities. Vamesh Chovatia, partner at Tata Capital Healthcare Fund II, continued, "We aim to work with Apex Kidney Care and make quality and cost-effective services available to nephrology patients.". A growth-stage PE fund with an emphasis on India's healthcare and lifesciences industry is Tata Capital Healthcare Fund. It has raised commitments of about $200 million across two funds and is sponsored by Tata Capital Limited, a division of Tata Sons Limited. final version." return the same